Chemoinformaics analysis of Lavandulyl isobutyrate
Molecular Weight | 224.344 | nRot | 6 |
Heavy Atom Molecular Weight | 200.152 | nRig | 3 |
Exact Molecular Weight | 224.178 | nRing | 0 |
Solubility: LogS | -4.112 | nHRing | 0 |
Solubility: LogP | 4.645 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 40.987 |
nHD | 0 | BPOL | 26.681 |
QED | 0.507 |
Synth | 3.356 |
Natural Product Likeliness | 1.845 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.047 |
Pgp-sub | 0.002 |
HIA | 0.007 |
CACO-2 | -4.428 |
MDCK | 0.0000273 |
BBB | 0.976 |
PPB | 0.844552 |
VDSS | 1.898 |
FU | 0.152013 |
CYP1A2-inh | 0.603 |
CYP1A2-sub | 0.173 |
CYP2c19-inh | 0.277 |
CYP2c19-sub | 0.897 |
CYP2c9-inh | 0.072 |
CYP2c9-sub | 0.474 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.48 |
CYP3a4-inh | 0.12 |
CYP3a4-sub | 0.314 |
CL | 12.255 |
T12 | 0.274 |
hERG | 0.018 |
Ames | 0.014 |
ROA | 0.027 |
SkinSen | 0.108 |
Carcinogencity | 0.288 |
EI | 0.752 |
Respiratory | 0.814 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.798139 |